Observational study on the effiacy of landiolol for the treatment of atrial tachyarrhythmias and predictor of outcome

Observational study on the effiacy of landiolol for the treatment of atrial tachyarrhythmias and predictor of outcome - Landiolol in atrial tachyarrhythmias

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033650

Enrollment

Registered

2018-08-07

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial tachyarrhythmias

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent continuous intravenous infusion of raniorolol for the treatment of atrial tachyarrhythmias

Exclusion criteria

Exclusion criteria: Patients that are ineligible for this study (such as lack of information)

Design outcomes

Primary

Measure	Time frame
Heart rate and blood pressure during intravenous infusion of landiolol	—

Secondary

Measure	Time frame
Restoration of sinus rhythm Left ventricular ejection fraction Plasma BNP Total death Hospitalization due to worsening heart failure	—

Countries

Japan

Contacts

Public ContactTsuyoshi Shiga

Tokyo Women's Medical University Department of Cardiology

shiga.tsuyoshi@twmu.ac.jp03-3353-8111

Outcome results